Thatiana de Jesus Pereira Pinto (Thatiana Pinto)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Cystic Fibrosis

Artificial Intelligence

Top Venues

Human vaccines & immunotherapeutics

Infectious diseases and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Phung Nguyen The Nguyen, Nguyen Thanh Hung, Gaurav Mathur, Thatiana de Jesus Pereira Pinto, Nguyen Hoan Le Minh
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam. Human vaccines & immunotherapeutics (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)